Besides, CSC biomarkers were validated in some studies, such as CD133, CD13, and EpCAM, where they exist in a minor fraction with tumorigenic ability in HCC [133,134,135,136,137]. This evidence concerns the gene EPCAM and hepatocellular carcinoma.